See more : FFW Corporation (FFWC) Income Statement Analysis – Financial Results
Complete financial analysis of Optimax Holdings Berhad (0222.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Optimax Holdings Berhad, a leading company in the industry within the sector.
- Swiss Life Holding AG (SWSDF) Income Statement Analysis – Financial Results
- NSE S.A. (ALNSE.PA) Income Statement Analysis – Financial Results
- YCQH Agricultural Technology Co. Ltd. (YCQH) Income Statement Analysis – Financial Results
- Canna Corporation (CNCC) Income Statement Analysis – Financial Results
- Victor Group Holdings Limited (VIG.AX) Income Statement Analysis – Financial Results
Optimax Holdings Berhad (0222.KL)
Website: https://www.optimax2u.com
About Optimax Holdings Berhad
Optimax Holdings Berhad, an investment holding company, provides eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases, such as cataracts, glaucoma, dry eye, conjunctivitis, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, ptosis, and other eye diseases and disorders. It also provides refractive surgery, consultation and dispensary, oculoplastic surgery, and eye examination services. In addition, the company markets food products. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. The company was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 114.12M | 108.00M | 88.90M | 58.02M | 62.71M |
| Cost of Revenue | 70.33M | 23.63M | 19.47M | 12.09M | 36.49M |
| Gross Profit | 43.78M | 84.37M | 69.43M | 45.93M | 26.21M |
| Gross Profit Ratio | 38.37% | 78.12% | 78.10% | 79.16% | 41.80% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 2.80M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 1.05M |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 3.85M |
| Other Expenses | 22.54M | 0.00 | 169.00K | 230.00K | 25.00K |
| Operating Expenses | 22.54M | 59.74M | 49.77M | 35.07M | 3.88M |
| Cost & Expenses | 92.87M | 83.38M | 69.24M | 47.16M | 3.88M |
| Interest Income | 205.00K | 108.00K | 191.00K | 31.00K | 48.00K |
| Interest Expense | 1.44M | 1.23M | 1.26M | 1.54M | 1.46M |
| Depreciation & Amortization | 7.34M | 7.82M | 6.58M | 5.96M | 3.90M |
| EBITDA | 28.59M | 32.56M | 26.43M | 17.17M | 17.89M |
| EBITDA Ratio | 25.05% | 30.14% | 29.73% | 29.58% | -6.18% |
| Operating Income | 21.24M | 24.63M | 19.66M | 11.09M | -3.88M |
| Operating Income Ratio | 18.62% | 22.80% | 22.11% | 19.11% | -6.18% |
| Total Other Income/Expenses | -1.23M | -1.12M | -1.07M | -1.42M | -1.41M |
| Income Before Tax | 20.01M | 23.51M | 18.59M | 9.67M | 12.57M |
| Income Before Tax Ratio | 17.53% | 21.76% | 20.91% | 16.67% | 20.05% |
| Income Tax Expense | 5.73M | 7.09M | 5.49M | 3.26M | 3.83M |
| Net Income | 12.89M | 14.69M | 12.30M | 5.64M | 7.83M |
| Net Income Ratio | 11.30% | 13.60% | 13.83% | 9.72% | 12.49% |
| EPS | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 |
| EPS Diluted | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 540.17M | 540.00M | 540.00M | 458.34M | 400.01M |
| Weighted Avg Shares Out (Dil) | 561.06M | 550.34M | 675.00M | 593.33M | 400.00M |
Source: https://incomestatements.info
Category: Stock Reports